Neurofilament light chain, glial fibrillary acidic protein and phosphorylated-tau 181 levels were elevated in early-onset Alzheimer’s disease compared with other diagnostic categories. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.